Evotaz Interactions
There are 627 drugs known to interact with Evotaz (atazanavir/cobicistat), along with 9 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 274 are major, 320 are moderate, and 33 are minor.
- View all 627 medications that may interact with Evotaz
- View Evotaz alcohol/food interactions (3)
- View Evotaz disease interactions (9)
Most frequently checked interactions
View interaction reports for Evotaz (atazanavir / cobicistat) and the medicines listed below.
- acyclovir
- alprazolam
- amlodipine
- amoxicillin
- atorvastatin
- azelastine nasal
- azithromycin
- buspirone
- ciprofloxacin
- clonazepam
- Descovy (emtricitabine / tenofovir alafenamide)
- doxepin
- doxycycline
- Edurant (rilpivirine)
- famotidine
- fenofibrate
- Flomax (tamsulosin)
- gabapentin
- hydrochlorothiazide
- Intelence (etravirine)
- lamotrigine
- lisinopril
- meclizine
- Reyataz (atazanavir)
- sertraline
- sildenafil
- Tivicay (dolutegravir)
- Truvada (emtricitabine / tenofovir disoproxil)
- venlafaxine
- Vitamin D3 (cholecalciferol)
Evotaz alcohol/food interactions
There are 3 alcohol/food interactions with Evotaz (atazanavir / cobicistat).
Evotaz disease interactions
There are 9 disease interactions with Evotaz (atazanavir / cobicistat) which include:
- heart block
- nephrolithiasis
- renal impairment
- liver disease
- PKU
- creatinine clearance
- hemophilia
- hyperglycemia
- hyperlipidemia
Report options
QR code containing a link to this page
More about Evotaz (atazanavir / cobicistat)
- Evotaz consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
